Multimodal Fusion of mpMRI Radiomics, Clinical Features, and Hematological Biomarkers Enhances Machine Learning‐Based Prediction of Biochemical Recurrence in Prostate Cancer Patients
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Yinxing Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Taizhou Affiliated Hospital of Nanjing University of Chinese Medicine, Taizhou, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Machine Learning, Biomarkers, Tumor, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Postgraduate Research & Practice Innovation Program of Jiangsu Province, Traditional Chinese Medicine Science and Technology Development Project of Jiangsu Province, Young Elite Scientists Sponsorship Program by Jiangsu Association of Chinese Medicine.
Themen: Künstliche Intelligenz in der Pflege, Onkologische Pflege
Abstract (Originalsprache)
To develop and validate an interpretable machine‐learning model for early prediction of biochemical recurrence (BCR) by fusing multiparametric MRI radiomics, clinical variables, and hematological biomarkers. A total of 172 patients (115 BCR‐positive, 57 BCR‐negative), who underwent RP with a median follow‐up of 37 months, from Taizhou People's Hospital were retrospectively enrolled. Preoperative ADC and T2‐weighted images were manually segmented to extract radiomic features; laboratory and clinical data included PSA, routine blood counts, lipid profile, and coagulation indices. After LASSO selection, seven machine‐learning algorithms were trained and internally validated. The best‐performing model was interpreted with SHAP analysis to quantify feature contributions. PSA emerged as the dominant predictor, exhibiting the highest mean absolute SHAP value and thereby exerting the greatest influence on model output. Among coagulation parameters, D‐dimer and APTT were significantly associated with BCR ( p = 0.007 and p = 0.036, respectively). Integration of ADC + T2 radiomics with clinical/hematological variables via a SVM classifier yielded the highest performance: AUC 0.916 (95% CI: 0.891–0.941) in the training set and 0.820 (95% CI: 0.762–0.878) in the validation set. SHAP revealed that ADC/T2 radiomic features constituted 60% of the top‐ten predictors, while D‐dimer exhibited a paradoxical negative SHAP value, suggesting a potential protective association. Multimodal fusion of mpMRI radiomics, clinical feature, and hematological biomarkers substantially improves BCR prediction. The interpretable model highlights PSA, and coagulation dysfunction, as key recurrence drivers, offering a clinically actionable tool for personalized management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Taizhou Affiliated Hospital of Nanjing University of Chinese Medicine, Taizhou, China.
- Xi'an Jiaotong-Liverpool University, Suzhou, China.
- Jiangsu University, Zhenjiang, China.
- The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China.
- Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
ORCID-Profile: Yinxing Zhu, Zeyu Yang, Zhipeng Liu, Shuai Xu, Xin Wang, Xiaowei Zhu, Lichao Qian
Förderung
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- Traditional Chinese Medicine Science and Technology Development Project of Jiangsu Province
- Young Elite Scientists Sponsorship Program by Jiangsu Association of Chinese Medicine
Zitieren
APA
Zhu, Y., Yang, Z., Liu, Z., Xu, S., Wang, X., Zhu, X., & Qian, L. (2025). Multimodal Fusion of mpMRI Radiomics, Clinical Features, and Hematological Biomarkers Enhances Machine Learning‐Based Prediction of Biochemical Recurrence in Prostate Cancer Patients. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70206
Vancouver
Zhu Y, Yang Z, Liu Z, Xu S, Wang X, Zhu X, et al. Multimodal Fusion of mpMRI Radiomics, Clinical Features, and Hematological Biomarkers Enhances Machine Learning‐Based Prediction of Biochemical Recurrence in Prostate Cancer Patients. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70206
BibTeX
@article{Zhu2025,
author = {Zhu, Yinxing and Yang, Zeyu and Liu, Zhipeng and Xu, Shuai and Wang, Xin and Zhu, Xiaowei and Qian, Lichao},
title = {Multimodal Fusion of mpMRI Radiomics, Clinical Features, and Hematological Biomarkers Enhances Machine Learning‐Based Prediction of Biochemical Recurrence in Prostate Cancer Patients},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70206}
}
EUVIMED